ArticleEuropean heart journal. Case reports2026
Lattice-shaped catheter ablation for incessant inducible AVNRT in patient undergoing atrial fibrillation ablation: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This report describes the first use of the Affera Sphere-9 dual-energy catheter for slow pathway modification in atrioventricular nodal re-entrant tachycardia (AVNRT) during atrial fibrillation (AF) ablation in a patient with a dual-chamber pacemaker, illustrating a streamlined single-catheter approach. Case presentation: A 74-year-old man with prior cryoablation for AF, mitral valve repair, and a recently implanted dual-chamber pacemaker was referred for repeat AF ablation due to symptomatic, recurrent AF (30% burden). Left atrial mapping with the Sphere-9 catheter revealed reconnection at the right superior pulmonary vein, right carina, and across prior roof and floor lines. Using pulsed field (4-s lesions, 8 mm spacing) and supplemental radiofrequency (RF) energy, the left atrial posterior wall was re-isolated. Cavo-tricuspid isthmus ablation was performed with RF and pulsed field applications, achieving bidirectional block. During subsequent testing, typical AVNRT was induced. To maximize efficiency, slow pathway modification was performed with the same Sphere-9 catheter, using shortened RF applications (3 s), a lower target temperature (60°C), and an 80% current limit, at an inferior-posterior site 1.3-2.5 cm from the His signal. Junctional acceleration was observed without atrioventricular block, indicating successful slow pathway modification. The procedure was completed without fluoroscopy or complications, and follow-up device interrogation showed no recurrence of AF or AVNRT. Conclusion: This case demonstrates the feasibility and acute safety of using a single dual-energy lattice-tip catheter for combined AF and AVNRT ablation, potentially reducing procedure time, catheter exchanges, and cost; larger studies are needed to assess long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.